1. Home
  2. EARN vs DERM Comparison

EARN vs DERM Comparison

Compare EARN & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.32

Market Cap

169.8M

Sector

Real Estate

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.23

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
DERM
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.8M
190.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
EARN
DERM
Price
$4.32
$7.23
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.38
$12.67
AVG Volume (30 Days)
356.2K
174.9K
Earning Date
06-16-2026
05-13-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
34.72
EPS
N/A
N/A
Revenue
N/A
$61,858,000.00
Revenue This Year
$7.69
$39.72
Revenue Next Year
$19.57
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.20
52 Week Low
$4.25
$4.31
52 Week High
$5.77
$9.56

Technical Indicators

Market Signals
Indicator
EARN
DERM
Relative Strength Index (RSI) 41.40 46.58
Support Level $4.29 $5.92
Resistance Level $4.49 $7.39
Average True Range (ATR) 0.07 0.38
MACD -0.01 -0.04
Stochastic Oscillator 2.38 4.55

Price Performance

Historical Comparison
EARN
DERM

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: